Session Leader: Amesh Adalja, Senior Scholar at the Johns Hopkins University Center for Health Security. Dr. Adalja is a global expert on pandemics and their consequences for public health, and population health.

 

The Forum focused on the lessons of the COVID pandemic, and how C-Suite executives in healthcare and the life sciences should respond.  

• How will the pandemic affect demand and funding for infectious disease treatment innovation? 

• Is there a new role for C-Suite leaders in public and population health policies?

• What may change in relations between industry, the FDA, and approval processes? 

• How can leaders capture and sustain the improved reputation of healthcare and the life sciences flowing from the vaccine victories? 

• How is that reputation impacted by the issues around safety and supply?